A Phase I/II Clinical Study to assess safety, potency and durability of SR-02 implanted to the abdominal omentum of patients with difficult-to-control T1D

Limulus Amebocyte Lysate (LAL) Can Now Be Produced Without Harvesting the Blood of ~800,000 Horseshoe Crabs Each Year, Which Will Help Restore Their Natural Population

Single-use bioreactors market is estimated to attain a CAGR of 20.2% through 2027 owing to various advantages such as reduced cross contamination, cost-effectiveness, flexibility and increased productivity.

Induced Pluripotent Stem Cells Forming an Emerging Market

AASCP will be holding their much anticipated meeting via virtual technology.

The Phase 2 study will assess the safety and efficacy of Longeveron's stem cell treatment under Japan's accelerated regulatory pathway for regenerative medicine.

Machine, Meet Stem Cells

AASCP is hosting an FDA Panel and many distinguished physicians this weekend at their annual Scientific Congress. All physicians practicing stem cell treatments should not miss this event on Nov. 1-3, 2019.

Safety Panel Discussion to be held at 3:00 p.m. on Nov. 2, 2019, moderated by Ms. Janet Marchbrody. Highly anticipated session will discuss the growing safety concerns of the industry.

American Academy of Stem Cell Physicians joins the Alliance for Cell Therapy Now to discuss industry safety standards

In Vitro Assay Accelerates Drug Development in Human-Relevant Heart Models

Breakthrough bioengineered, decellularized Wharton's Jelly matrix platform facilitates precision in vitro targeting of cancer stem cells (CSCs).

The Sanatela™ Matrix is a revolutionary, natural 3-D biomaterial that gives researchers a tool to cultivate and study stem cells, including cancer stem cells. This matrix tissue opens new research opportunities for the development of individualized cancer treatments in the lab and for High-Throughput Drug Screening applications by pharmaceutical and biotechnology companies.

Dr. Steven Victor and ReGen Medical will be doing Stem Cell Consultations and Treatments at the Valiant Clinic City Walk Dubai UAE

Advances in Regenerative Medicine Key to Patients' Return to Pain-Free, Active Lifestyle

Dr. Steven Victor Co-Author of "Stem Cells and Regenerative Therapies: Clarification of Terminology and Potential Applications in Aging and Neurodegenerative Disorders"

Dr. Steven Victor, the only DHA-licensed physician in regenerative medicine in UAE, opens up at the Valiant Clinic, Meraas City Walk, Dubai, UAE

In Vitro Approach Provides Predictive Platform for Human-Based Drug Discovery

Keller's work with pluripotent stem cells has led to a platform for disease modeling and regenerative medicine

See it First: New Waterless Skincare Line Activates Dormant Stem Cells

Dr. Steven Victor will continue treatments of autism at the Emirates Hospital Jumeriah Dubai with Stem Cell Therapy.

Demonstrates platform's ability to engineer mature human cardiac tissue and generate models of human heart disease starting from patient iPSCs

Dr. Steven Victor was Interviewed on DubaiTV by Diala Makki on Nov. 9 Discussing His Stem Therapy in Dubai

Dr. Steven Victor and ReGen Medical will be doing Stem Cell Consultations and Treatments at the Emirates Hospital Jumeriah Dubai.

Dr. Steven Victor and ReGen Medical are Bringing Stem Cell Treatments to Dubai for Anti-Aging and Rejuvenation

13th International Conference on Medical Regulation (IAMRA) in Association with the Dubai Health Regulation Conference 2018

New discoveries about how cells self-organize could help researchers create more authentic organ models for research or transplantation

Sold out Exhibit halls, state of the art technology and innovative treatments discussed, the best in Regenerative medicine!

Caroline Stanbury Rejuvenation

"ReGen at Emirates Hospital" will be the first in the UAE to offer specialty regenerative services.

Scaling platform and building high-fidelity human-relevant datasets for in silico drug discovery

Scientists at Gladstone reveal how the virus decides between fates.

Researchers at the Gladstone Institutes provide answers to decade-old questions

Dr. Farshchian confirms the first meeting of The American Association of Stem Cell Physicians (AAOSCP) to spread the knowledge of therapeutics in Regenerative medicine.

Dr. Farshchian discusses a new innovative live cell treatment for Alzheimer's.

Activating a single gene is sufficient to change skin cells into stem cells.

Market Size, Segments, Storage Rates, Utilization, and Projections Through 2022

All-time quarterly sales achieved resulting from a surge in family enquiries.

BioInformant is launching the "Market for Stem Cell Exosomes - Products, Services, & Technologies," a global strategic report targeting the growing demand for exosome therapeutics, diagnostics, and research tools.

The discovery could improve treatments for autoimmune diseases and cancer

Gladstone scientists are the first to produce a type of stem cell-derived neuron that could potentially help restore movement